2023
DOI: 10.1158/1535-7163.22506906.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Supplementary Tables S1-S2 from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors

Abstract: <p>Supplementary Table S1. Commercial tumor TMAs representing different solid tumor types. Supplementary Table S2. Summary of CD205 expression in human solid tumor types.</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles